{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:35:49Z","timestamp":1768955749828,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.clgc.2025.102482","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T16:49:40Z","timestamp":1765471780000},"page":"102482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of Fat and Muscle Mass With Overall Survival in Patients With Metastatic Prostate Cancer Treated With Enzalutamide, Abiraterone, and Docetaxel"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6624-8063","authenticated-orcid":false,"given":"\u0130hsan","family":"Solmaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8168-136X","authenticated-orcid":false,"given":"Halil","family":"K\u00f6mek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8875-5672","authenticated-orcid":false,"given":"Fethullah","family":"Kayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0255-5830","authenticated-orcid":false,"given":"Canan","family":"Can","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5727-4702","authenticated-orcid":false,"given":"\u0130hsan","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8505-8088","authenticated-orcid":false,"given":"R\u0131dvan","family":"Kili\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8555-0460","authenticated-orcid":false,"given":"Yunus","family":"G\u00fczel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9422-1346","authenticated-orcid":false,"given":"Mehmet Serdar","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4039-1256","authenticated-orcid":false,"given":"\u00d6mer Faruk","family":"Alaku\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5795-533X","authenticated-orcid":false,"given":"Bilgin Bahad\u0131r","family":"Ba\u015fg\u00f6z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4797-7017","authenticated-orcid":false,"given":"Mehmet","family":"\u00d6zel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6041-3817","authenticated-orcid":false,"given":"E\u015fref","family":"Ara\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clgc.2025.102482_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"10.1016\/j.clgc.2025.102482_bib0002","doi-asserted-by":"crossref","first-page":"803","DOI":"10.4045\/tidsskr.16.0265","article-title":"Modern treatment of metastatic prostate cancer","volume":"137","author":"Holm","year":"2017","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"4","key":"10.1016\/j.clgc.2025.102482_bib0003","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.eururo.2016.08.002","article-title":"EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer","volume":"71","author":"Cornford","year":"2017","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102482_bib0004","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1158\/1055-9965.EPI-16-0439","article-title":"The obesity paradox in cancer-moving beyond BMI","volume":"26","author":"Strulov Shachar","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.clgc.2025.102482_bib0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.clgc.2025.102482_bib0006","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejca.2015.12.030","article-title":"Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review","volume":"57","author":"Shachar","year":"2016","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.clgc.2025.102482_bib0007","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1186\/s12885-017-3562-4","article-title":"Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non-small-cell lung cancer","volume":"17","author":"Naito","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clgc.2025.102482_bib0008","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.clgc.2025.102482_bib0009","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/0148607113502674","article-title":"Prevalence of malnutrition and current use of nutrition support in patients with cancer","volume":"38","author":"H\u00e9buterne","year":"2014","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"2","key":"10.1016\/j.clgc.2025.102482_bib0010","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.critrevonc.2008.06.006","article-title":"Body composition changes during androgen deprivation therapy for prostate cancer: a 2-year prospective study","volume":"68","author":"van Londen","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"issue":"26","key":"10.1016\/j.clgc.2025.102482_bib0011","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1200\/JCO.2011.38.8850","article-title":"Sarcopenia during androgen-deprivation therapy for prostate cancer","volume":"30","author":"Smith","year":"2012","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.clgc.2025.102482_bib0012","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/JU.0000000000001428","article-title":"Obesity is associated with longer survival independent of sarcopenia and myosteatosis in metastatic and\/or castrate-resistant prostate cancer","volume":"205","author":"Xu","year":"2021","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.clgc.2025.102482_bib0013","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41391-021-00442-0","article-title":"Associations of fat and muscle mass with overall survival in men with prostate cancer: a systematic review with meta-analysis","volume":"25","author":"Lopez","year":"2022","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3","key":"10.1016\/j.clgc.2025.102482_bib0014","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/JU.0000000000001428","article-title":"Obesity is associated with longer survival independent of sarcopenia and myosteatosis in metastatic and\/or castrate-resistant prostate cancer","volume":"205","author":"Xu","year":"2021","journal-title":"J Urol"},{"issue":"7","key":"10.1016\/j.clgc.2025.102482_bib0015","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/cncr.22932","article-title":"Inverse correlation between body mass index and clinical outcomes in men with advanced castration-recurrent prostate cancer","volume":"110","author":"Halabi","year":"2007","journal-title":"Cancer"},{"issue":"17","key":"10.1016\/j.clgc.2025.102482_bib0016","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1016\/j.ejca.2015.07.042","article-title":"High subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy setting","volume":"51","author":"Antoun","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clgc.2025.102482_bib0017","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/j.clnesp.2016.04.001","article-title":"Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel","volume":"13","author":"Cushen","year":"2016","journal-title":"Clin Nutr ESPEN"},{"issue":"7","key":"10.1016\/j.clgc.2025.102482_bib0018","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102482_bib0019","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1152\/jappl.1998.85.1.115","article-title":"Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography","volume":"85","author":"Mitsiopoulos","year":"1985","journal-title":"J Appl Physiol"},{"issue":"5","key":"10.1016\/j.clgc.2025.102482_bib0020","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102482_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00280-018-3614-8","article-title":"Interactions of lean soft-tissue and chemotherapy toxicities in patients receiving anti-cancer treatments","volume":"82","author":"Hopkins","year":"2018","journal-title":"Cancer Chemother Pharmacol"},{"issue":"8","key":"10.1016\/j.clgc.2025.102482_bib0022","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1007\/s12094-024-03421-8","article-title":"Sarcopenia among treated cancer patients before and after neoadjuvant chemotherapy: a systematic review and meta-analysis of high-quality studies","volume":"26","author":"Su","year":"2024","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102482_bib0023","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12957-024-03304-w","article-title":"Correlation between sarcopenia and esophageal cancer: a narrative review","volume":"22","author":"Li","year":"2024","journal-title":"World J Surg Oncol"},{"issue":"11","key":"10.1016\/j.clgc.2025.102482_bib0024","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1080\/10428194.2024.2371500","article-title":"Sarcopenia is a prognostic factor in lymphoma patients: a systematic review and meta-analysis","volume":"65","author":"Li","year":"2024","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clgc.2025.102482_bib0025","article-title":"Sarcopenia has a negative impact on survival outcomes in ovarian cancer: a systematic review and meta-analysis","author":"Zhang","year":"2024","journal-title":"Asian J Surg"},{"key":"10.1016\/j.clgc.2025.102482_bib0026","article-title":"The prognostic value of pre-treatment sarcopenia in overall survival in head and neck cancer patients: a systematic review","author":"Syziu","year":"2024","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"1","key":"10.1016\/j.clgc.2025.102482_bib0027","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.prnil.2018.04.002","article-title":"Sarcopenia is a poor prognostic factor of castration-resistant prostate cancer treated with docetaxel therapy","volume":"7","author":"Ohtaka","year":"2019","journal-title":"Prostate Int"},{"issue":"8","key":"10.1016\/j.clgc.2025.102482_bib0028","article-title":"Sarcopenia evaluated by EASL\/AASLD computed tomography-based criteria predicts mortality in patients with cirrhosis: a systematic review and meta-analysis","volume":"6","author":"Dajti","year":"2024","journal-title":"Jhep Rep"},{"issue":"38","key":"10.1016\/j.clgc.2025.102482_bib0029","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017213","article-title":"Prognostic value of radiologically determined sarcopenia prior to treatment in urologic tumors: a meta-analysis","volume":"98","author":"Li","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"10.1016\/j.clgc.2025.102482_bib0030","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.3390\/nu15071631","article-title":"Androgen deprivation therapy for prostate cancer influences body composition increasing risk of sarcopenia","volume":"15","author":"Korczak","year":"2023","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.clgc.2025.102482_bib0031","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1467-789X.2009.00623.x","article-title":"Subcutaneous and visceral adipose tissue: structural and functional differences","volume":"11","author":"Ibrahim","year":"2010","journal-title":"Obes Rev"},{"issue":"4","key":"10.1016\/j.clgc.2025.102482_bib0032","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.numecd.2006.07.005","article-title":"The link between abdominal obesity, metabolic syndrome and cardiovascular disease","volume":"17","author":"Ritchie","year":"2007","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.clgc.2025.102482_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101398","article-title":"Updated systematic review and meta-analysis on diagnostic issues and the prognostic impact of myosteatosis: a new paradigm beyond sarcopenia","volume":"70","author":"Ahn","year":"2021","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.clgc.2025.102482_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2019.102839","article-title":"Myosteatosis and prognosis in cancer: systematic review and meta-analysis","volume":"145","author":"Aleixo","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.clgc.2025.102482_bib0035","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9242243","article-title":"Clinical features and body composition in men with hormone-sensitive metastatic prostate cancer: a pilot study examining differences by race","volume":"2022","author":"Sheean","year":"2022","journal-title":"Prostate Cancer"},{"key":"10.1016\/j.clgc.2025.102482_bib0036","article-title":"Impact of sarcopenic obesity on surgical complications and oncologic outcomes of upper gastrointestinal tumors: a systematic review and meta-analysis","author":"Juez","year":"2024","journal-title":"Cir Esp"},{"key":"10.1016\/j.clgc.2025.102482_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euros.2023.09.004","article-title":"Profiling of skeletal muscle and adipose tissue depots in men with advanced prostate cancer receiving different forms of androgen deprivation therapy","volume":"57","author":"Blow","year":"2023","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.clgc.2025.102482_bib0038","article-title":"Influence of abiraterone and enzalutamide on body composition in patients with metastatic castration resistant prostate cancer","volume":"25","author":"Fischer","year":"2020","journal-title":"Cancer Treat Res Commun"},{"issue":"3","key":"10.1016\/j.clgc.2025.102482_bib0039","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.clgc.2017.11.007","article-title":"Comparison of alternative androgen receptor-axis-targeted agent (ARATA) and Docetaxel as second-line therapy for patients with metastatic castration-resistant prostate cancer with progression after initial ARATA in real-world clinical practice in Japan","volume":"16","author":"Miyake","year":"2018","journal-title":"Clin Genitourin Cancer"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155876732500182X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155876732500182X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T12:10:07Z","timestamp":1768911007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155876732500182X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S155876732500182X"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102482","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Fat and Muscle Mass With Overall Survival in Patients With Metastatic Prostate Cancer Treated With Enzalutamide, Abiraterone, and Docetaxel","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102482","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102482"}}